George Simeon
CIK: 0001595117
Director10% Owner
Primary company: CRISPR Therapeutics AG (CRSP)
George Simeon is a corporate insider at CRISPR Therapeutics AG (CRSP) filing SEC Form 4 transactions. 84 transactions across 6 companies, totaling $130,170,212 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Nkarta, Inc. NKTX | Award | 37,000 | $2.46 | $91K | 37,000 | 6/10/2026 Filed: 6/10/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 13,000 | $51.84 | $674K | 13,000 | 6/5/2026 Filed: 6/5/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Purchase | 960,983 | $52.03 | $50.00M | 1,730,179 | 7/16/2025 Filed: 7/17/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Purchase | 22,319 | $52.03 | $1.16M | 238,897 | 7/16/2025 Filed: 7/17/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Purchase | 6,510 | $52.03 | $339K | 69,687 | 7/16/2025 Filed: 7/17/2025 | Filing → |
| Award | 19,000 | - | - | 19,000 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
Nkarta, Inc. NKTX | Award | 46,000 | - | - | 46,000 | 6/5/2025 Filed: 6/9/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 13,000 | - | - | 13,000 | 6/5/2025 Filed: 6/6/2025 | Filing → |
| Award | 19,000 | - | - | 19,000 | 6/13/2024 Filed: 6/17/2024 | Filing → | |
Nkarta, Inc. NKTX | Award | 22,500 | - | - | 22,500 | 6/13/2024 Filed: 6/14/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 13,000 | - | - | 13,000 | 5/30/2024 Filed: 5/31/2024 | Filing → |
Nkarta, Inc. NKTX | Purchase | 451,659 | $10.00 | $4.52M | 451,659 | 3/27/2024 Filed: 3/28/2024 | Filing → |
Nkarta, Inc. NKTX | Purchase | 1,548,341 | $10.00 | $15.48M | 1,548,341 | 3/27/2024 Filed: 3/28/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 769,196 | $71.50 | $55.00M | 769,196 | 2/27/2024 Filed: 2/27/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 216,578 | $71.50 | $15.49M | 216,578 | 2/27/2024 Filed: 2/27/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 63,177 | $71.50 | $4.52M | 63,177 | 2/27/2024 Filed: 2/27/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 13,000 | $0.00 | $0 | 13,000 | 6/8/2023 Filed: 6/9/2023 | Filing → |
Nkarta, Inc. NKTK | Award | 22,500 | $0.00 | $0 | 22,500 | 6/7/2023 Filed: 6/9/2023 | Filing → |
| Award | 15,000 | $0.00 | $0 | 15,000 | 5/31/2023 Filed: 6/2/2023 | Filing → | |
| Purchase | 40,000 | $8.14 | $325K | 6,526,476 | 12/20/2022 Filed: 12/20/2022 | Filing → |
Nkarta, Inc.
NKTX
Type
Award
Shares
37,000
Price
$2.46
Value
$91K
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
13,000
Price
$51.84
Value
$674K
CRISPR Therapeutics AG
CRSP
Type
Purchase
Shares
960,983
Price
$52.03
Value
$50.00M
CRISPR Therapeutics AG
CRSP
Type
Purchase
Shares
22,319
Price
$52.03
Value
$1.16M
CRISPR Therapeutics AG
CRSP
Type
Purchase
Shares
6,510
Price
$52.03
Value
$339K
Type
Award
Shares
19,000
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Award
Shares
46,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
13,000
Price
-
Value
-
Type
Award
Shares
19,000
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Award
Shares
22,500
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
13,000
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Purchase
Shares
451,659
Price
$10.00
Value
$4.52M
Nkarta, Inc.
NKTX
Type
Purchase
Shares
1,548,341
Price
$10.00
Value
$15.48M
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
769,196
Price
$71.50
Value
$55.00M
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
216,578
Price
$71.50
Value
$15.49M
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
63,177
Price
$71.50
Value
$4.52M
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
13,000
Price
$0.00
Value
$0
Nkarta, Inc.
NKTK
Type
Award
Shares
22,500
Price
$0.00
Value
$0
Type
Award
Shares
15,000
Price
$0.00
Value
$0
Type
Purchase
Shares
40,000
Price
$8.14
Value
$325K
AI Agent
Try asking...